PX 12
SIGMA/M5324 - ≥98% (HPLC), powder
Synonym: 2-
CAS Number: 141400-58-0
Empirical Formula (Hill Notation): C7H12N2S2
Molecular Weight: 188.31
MDL Number: MFCD18086851
Linear Formula: C7H12N2S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white to tan |
| form | powder |
| InChI | 1S/C7H12N2S2/c1-3-6(2)10- |
| InChI key | BPBPYQWMFCTCNG-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CCC(C)SSc1ncc[nH]1 |
| solubility | DMSO: >25 mg/mL |
| storage temp. | 2-8°C |
| Application: | PX 12 has been used as a thioredoxin 1 inhibitor prostate cancer cell lines to analyse its effect on cell viability. It has also been used as a hypoxia-inducible factor (HIF)-1α inhibitor to treat H2228 cells. |
| Biochem/physiol Actions: | PX 12 is a thioredoxin inhibitor. |
| Biochem/physiol Actions: | PX-12 inhibits the thioredoxin redox system and HIF-1a activity. PX 12 inhibits hypoxia-induced HIF-1a transcriptional activity (IC50 11 nM) and proliferation of HT29 and MCF-7 tumor cells (IC50 1.9 and 0.9 uM, respectively). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


